Bio Rad Laboratories Inc (NYSE:BIO)

301.46
Delayed Data
As of Jun 18
 -2.42 / -0.80%
Today’s Change
208.95
Today|||52-Week Range
304.36
+26.31%
Year-to-Date
6 Stocks Beating the Market
Jun 13 / GuruFocus News - Paid Partner Content
Bio-Rad Banks on Solid Global Scenario, Competition Rife
Jun 08 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close303.88
Today’s open301.91
Day’s range299.54 - 303.02
Volume178,563
Average volume (3 months)158,231
Market cap$7.1B
Data as of 4:02pm ET, 06/18/2018

Growth & Valuation

Earnings growth (last year)+328.42%
Earnings growth (this year)+60.50%
Earnings growth (next 5 years)+36.18%
Revenue growth (last year)+4.45%
P/E ratio11.9
Price/Sales3.32
Price/Book2.92

Competitors

 Today’s
change
Today’s
% change
BRKRBruker Corp-0.47-1.46%
PKIPerkinElmer Inc-0.31-0.40%
QGENQiagen NV-0.39-1.05%
AXDXAccelerate Diagnosti...+0.35+1.51%
Data as of 4:02pm ET, 06/18/2018

Financials

Next reporting dateAugust 7, 2018
EPS forecast (this quarter)$1.14
Annual revenue (last year)$2.2B
Annual profit (last year)$122.2M
Net profit margin5.66%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Norman D. Schwartz
Chief Financial Officer &
Executive Vice President
Christine A. Tsingos
Corporate headquarters
Hercules, California

Forecasts